Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MME | P08473 | 2/20 | 0.57 |
| ▸ | MMP2 | P08253 | 4/20 | 0.57 |
| ▸ | MMP9 | P14780 | 3/20 | 0.57 |
| ▸ | ADAMTS4 | O75173 | 1/20 | 0.57 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.55 |
| ▸ | NAALAD2 | Q9Y3Q0 | 2/20 | 0.54 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.53 |
| ▸ | ACE | P12821 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.53 |
| ▸ | ALPI | P09923 | 1/20 | 0.52 |
| ▸ | PKM | P14618 | 1/20 | 0.52 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.52 |
| ▸ | XIAP | P98170 | 1/20 | 0.52 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL144009 | 1.00 | MME (0.57) | MMEMMP2MMP9ADAMTS4NPSR1 | |
| SCHEMBL199980 | 1.00 | MME (0.57) | MMEMMP2MMP9ADAMTS4NPSR1 | |
| SCHEMBL144008 | 1.00 | MME (0.57) | MMEMMP2MMP9ADAMTS4NPSR1 | |
| Trifluoroacetic Acid SCHEMBL31261334 | 0.93 | ACE (0.55) | MMEMMP2MMP9ADAMTS4NPSR1 | |
| SCHEMBL8501294 | 0.86 | NAALAD2 (0.47) | MMEMMP2MMP9ADAMTS4NPSR1 | |
| SCHEMBL1008925 | 0.85 | FOLH1 (0.56) | MMENAALAD2FOLH1L3MBTL1ACE | |
| SCHEMBL22290826 | 0.85 | ALDH1A1 (0.57) | MMEFOLH1ACEALDH1A1 | |
| SCHEMBL29964738 | 0.85 | ALDH1A1 (0.57) | MMEFOLH1ACEALDH1A1 | |
| SCHEMBL1008926 | 0.85 | FOLH1 (0.56) | MMENAALAD2FOLH1L3MBTL1ACE | |
| SCHEMBL15833929 | 0.85 | EPHX1 (0.53) | MMENPSR1CYP1A2ALPIPKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240383827-A1 | DIFLUOROCARBENE RADIOSYNTHESIS | OXFORD UNIVERSITY INNOVATION LIMITED (GB) | 2024-11-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240383827-A1 | DIFLUOROCARBENE RADIOSYNTHESIS | RFC2, FDFT1, AFF1 | MME 2777/4885MMP2 3868/4885MMP9 4152/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.